Morgan Stanley’s SPDR S&P Pharmaceuticals ETF XPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $20.1M | Sell |
|
|||||
|
2025
Q1 | $21.9M | Sell |
|
|||||
|
2024
Q4 | $26.4M | Buy |
|
|||||
|
2024
Q3 | $4.87M | Sell |
|
|||||
|
2024
Q2 | $5.08M | Sell |
|
|||||
|
2024
Q1 | $7.89M | Sell |
|
|||||
|
2023
Q4 | $32.5M | Buy |
|
|||||
|
2023
Q3 | $12.7M | Sell |
|
|||||
|
2023
Q2 | $15.7M | Sell |
|
|||||
|
2023
Q1 | $23.9M | Sell |
|
|||||
|
2022
Q4 | $26.2M | Sell |
|
|||||
|
2022
Q3 | $31.3M | Buy |
|
|||||
|
2022
Q2 | $28.1M | Buy |
|
|||||
|
2022
Q1 | $23.3M | Sell |
|
|||||
|
2021
Q4 | $24.8M | Buy |
|
|||||
|
2021
Q3 | $19.1M | Sell |
|
|||||
|
2021
Q2 | $21.4M | Sell |
|
|||||
|
2021
Q1 | $24.2M | Sell |
|
|||||
|
2020
Q4 | $25.9M | Buy |
|
|||||
|
2020
Q3 | $18M | Sell |
|
|||||
|
2020
Q2 | $18.9M | Sell |
|
|||||
|
2020
Q1 | $29.3M | Buy |
|
|||||
|
2019
Q4 | $15.7M | Sell |
|
|||||
|
2019
Q3 | $12.4M | Sell |
|
|||||
|
2019
Q2 | $16.4M | Sell |
|
|||||
|
2019
Q1 | $30.1M | Sell |
|
|||||
|
2018
Q4 | $31.1M | Sell |
|
|||||
|
2018
Q3 | $42.6M | Buy |
|
|||||
|
2018
Q2 | $25.1M | Sell |
|
|||||
|
2018
Q1 | $34.2M | Buy |
|
|||||
|
2017
Q4 | $24.7M | Sell |
|
|||||
|
2017
Q3 | $27.3M | Buy |
|
|||||
|
2017
Q2 | $26.6M | Buy |
|
|||||
|
2017
Q1 | $25.8M | Buy |
|
|||||
|
2016
Q4 | $12.6M | Buy |
|
|||||
|
2016
Q3 | $12.3M | Sell |
|
|||||
|
2016
Q2 | $15.6M | Sell |
|
|||||
|
2016
Q1 | $19.6M | Sell |
|
|||||
|
2015
Q4 | $43M | Sell |
|
|||||
|
2015
Q3 | $40.5M | Sell |
|
|||||
|
2015
Q2 | $73.6M | Buy |
|
|||||
|
2015
Q1 | $69.4M | Sell |
|
|||||
|
2014
Q4 | $61.5M | Sell |
|
|||||
|
2014
Q3 | $61.6M | Buy |
|
|||||
|
2014
Q2 | $60.1M | Sell |
|
|||||
|
2014
Q1 | $58.4M | Buy |
|
|||||
|
2013
Q4 | $46.9M | Sell |
|
|||||
|
2013
Q3 | $41.2M | Buy |
|
|||||
|
2013
Q2 | $37M | Buy |
|